Amarantus Bioscience Holdings Inc (AMBS)

[JoeForkeyBolo]

Todos Medical to launch its cPass blood test that tests for antibodies in September this year

Todos Medical Ltd CEO Gerald Commissiong caught up with Proactive New York to talk about its expectation to launch the group's cPass blood test in September this year, which could play a key role in the USA's rollout of coronavirus booster jabs.

Commissiong says it comes after the firm's certified lab Provista Diagnostics successfully completed the validation studies required to put the cPass neutralizing antibody blood test into production. Todos sees a large market opportunity developing for cPass that will expand upon the coronavirus PCR testing market that rapidly developed into a worldwide $80 billion market last year.

Note: Amarantus shareholders have a stake in Todos Medical